News

Vator Securities advises Respiratorius on 25 MSEK Directed Share Issue

13 April 2021

Vator Securities acts as Financial Adviser in connection with the transaction raising SEK 25 million.

Respiratorius AB is developing drug candidates with the goal to launch drugs for common diseases cancer, chronic obstructive pulmonary disease (COPD) and severe asthma. In addition, the project portfolio is a project for improved diagnosis of certain cardiovascular diseases.

Read More

Vator Securities advises Sprint Bioscience on 21 MSEK Directed Share Issue

8 April 2021

Vator Securities acts as Financial Adviser in connection with the transaction raising SEK 21 million.

Sprint Bioscience develops small-molecule first-in-class drug projects with a focus on oncology. With a fragment-based drug development method, the company develops drug projects in a time- and resource-efficient way that is outlicensed to global pharmaceutical companies during the preclinical phase.

Read More

Vator Securities advises Epulze on 57 MSEK Private Placement

6 April 2021

Vator Securities acts as Financial Adviser in connection with the transaction raising SEK 57 million.

Epulze gives amateur players of computer games like Dota 2 and Counter-Strike: Global Offensive, the opportunity to participate in tournaments, leagues, and matches where real money is at stake. Among the new investors are well-known names such as Svea Ekonomi and Norwegian Carucel Finance, while Knutsson Holdings increases its ownership in the company.

Read More

Vator Securities advises CombiGene on 75 MSEK Rights Issue

8 March 2021

Vator Securities acts as Financial Adviser in connection with the transaction raising approximately SEK 75 million.

Having established the production platform for CG01, CombiGene’s intention in 2021 is to focus on the final parts of the preclinical program for CG01 with two major preclinical studies, a biodistribution study and a safety study, which will be conducted together with CombiGene’s CRO partners Northern Biomedical Research and Neurochase.

Read More

Vator Securities Events

15 February 2021

Vator Securities Tech Days are investor events with some of the most interesting and fast-growing tech companies in the Nordics.

Vator Securities presents a focused insight into the spectrum of tech companies including expert sessions related to the tech industry.

Read More

IBD Junior Analyst – Corporate Finance till Vator Securities

15 January 2021

Som junior analytiker kommer fokus ligga på att assistera dina kollegor vid framtagandet av företagspresentationer, arbeta med research, samt bistå med administration kring transaktioner och projekt.

Teamet består idag av 9 personer och kommer att utökas med ytterligare juniora talanger.

Read More